News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • OpenAI ends Microsoft's exclusivity, widening cloud competition and prompting a roughly 2–3% drop in Microsoft shares.
  • Gulf economies face their deepest downturn since the pandemic as the Iran conflict disrupts energy flows and lifts oil about 40%.
  • Goldman names five favored oil stocks as the industry enters a new capex phase, highlighting upside in energy equities.
  • Marvell-owned buyer cancels all POET purchase orders, sending POET Technologies shares sharply lower.
  • Germany's finance ministry says it could temporarily suspend the constitutional debt brake to finance emergency spending tied to the Iran war.
  • Macquarie-led group is nearing a $5.75–$6 billion sale of Louisiana utility Cleco, underlining private-equity demand in regulated assets.

Latest Articles

Exzeo CEO Purchases $29,980 of Stock as Shares Trade Below Purchase Price

Exzeo CEO Purchases $29,980 of Stock as Shares Trade Below Purchase Price

Exzeo Group Chief Executive Officer Paresh Patel acquired 2,000 shares of company common stock at $14.99 per share on March 24, 2026, for a total of $29,980. The purchase comes while the shares have fallen 39% year-to-date and are trading at $14.81; Exzeo reported fourth-quarter and full-year 2025 results that matched analysts' forecasts, with dilu…

Guardian Pharmacy CFO Disposes $5.6 Million in Stock Amid Recent Offering

Guardian Pharmacy CFO Disposes $5.6 Million in Stock Amid Recent Offering

Guardian Pharmacy Services CFO David K. Morris sold 187,855 Class A shares on March 20, 2026, for roughly $5.576 million under an underwriting agreement dated March 18, 2026. The shares have since risen to $37.57, near their 52-week high, while analysts lifted price targets after the company's solid fourth-quarter results. A recent underwritten off…

Blue Owl: A Tactical Long Against Panic, Not a Systemic Bust

Blue Owl: A Tactical Long Against Panic, Not a Systemic Bust

Blue Owl (OWL) has been punished on private credit redemption headlines and short-term liquidity worries. Fundamentals — significant free cash flow, a sub-$10B enterprise value and an oversold technical set-up — argue for a tactical long. This trade lays out exact entry, stop and target with a 45 trading-day horizon and clear risk controls.

AtaiBeckley CMO Disposes $355,000 in Shares After Option Exercises

AtaiBeckley CMO Disposes $355,000 in Shares After Option Exercises

AtaiBeckley Inc.'s Chief Medical Officer, Craig Kevin James, sold 100,000 shares of common stock on March 20, 2026, at $3.55 per share, generating $355,000. On the same date he exercised options to acquire 100,000 shares in two tranches. The company has seen notable index inclusions and released Phase 2a results for its nasal spray candidate BPL-00…

Neuronetics EVP Sells Shares to Cover Tax on Vesting Awards

Neuronetics EVP Sells Shares to Cover Tax on Vesting Awards

Neuronetics Executive Vice President and CFO Steven Pfanstiel sold 16,431 shares on March 19, 2026 to meet tax obligations tied to performance-restricted stock units. The transaction, executed between $1.20 and $1.48 per share for roughly $22,017, leaves Pfanstiel with 828,781 shares. The stock trades near its fair value amid recent price volatilit…